Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population

Selby, Joseph V.; Ray, G. Thomas; Zhang, D; Colby, Chris

doi:10.2337/diacare.20.9.1396

Cited by 319 publications

(220 citation statements)

References 0 publications

Supporting

Mentioning

200

Contrasting

Unclassified

Order By: Relevance

“…Recent data suggest that lifestyle interventions to prevent diabetes may overcome the genetic risk of diabetes. 39 This information may be helpful to Finally, because most of the direct costs for diabetes are associated with treating complications of diabetes, 40 a managed care organization like KP, which is not dependent on fee-for-service reimbursement, may be in a unique position to help implement upstream programs in schools and community programs now to prevent prediabetes, diabetes, and complications of diabetes. 41 …”

Section: Pharmacologic and Surgical Interventionmentioning

confidence: 99%

Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease

Tuso

2014

TPJ

199

143

View full text Add to dashboard Cite

Section: Pharmacologic and Surgical Interventionmentioning

confidence: 99%

Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease

Tuso

2014

TPJ

199

143

View full text Add to dashboard Cite

“…34,[37][38][39][40] Coexisting illnesses of interest included diabetes mellitus, hypertension, coronary heart disease, heart failure, and chronic lung or liver disease. Body mass index category 41 and tobacco history were ascertained from ambulatory visit databases.…”

Section: Covariatesmentioning

confidence: 99%

CKD and the Risk of Incident Cancer

Lowrance

Ordoñez

Udaltsova

et al. 2014

Journal of the American Society of Nephrology

231

183

View full text Add to dashboard Cite

Previous studies report a higher risk of cancer in patients with ESRD, but the impact of less severe CKD on risk of cancer is uncertain. Our objective was to evaluate the association between level of kidney function and subsequent cancer risk. We performed a retrospective cohort study of 1,190,538 adults who were receiving care within a health care delivery system, had a measurement of kidney function obtained between 2000 and 2008, and had no prior cancer. We examined the association between level of eGFR and the risk of incident cancer; the primary outcome was renal cancer, and secondary outcomes were any cancer and specific cancers (urothelial, prostate, breast, lung, and colorectal). During 6,000,420 person-years of follow-up, we identified 76,809 incident cancers in 72,875 subjects. After adjustment for time-updated confounders, lower eGFR (in milliliters per minute per 1.73 m 2 ) was associated with an increased risk of renal cancer (adjusted hazard ratio [HR], 1.39; 95% confidence interval [95% CI], 1.22 to 1.58 for eGFR=45-59; HR, 1.81; 95% CI, 1.51 to 2.17 for eGFR=30-44; HR, 2.28; 95% CI, 1.78 to 2.92 for eGFR,30). We also observed an increased risk of urothelial cancer at eGFR,30 but no significant associations between eGFR and prostate, breast, lung, colorectal, or any cancer overall. In conclusion, reduced eGFR is associated with an independently higher risk of renal and urothelial cancer but not other cancer types.

show abstract

“…Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain Type 2 (non-insulin-dependent) diabetes mellitus is a progressive chronic disease with long-term complications causing high associated morbidity and a considerable economic and social burden [1,2,3]. Diabetic patients often develop cardiovascular disease and it is the main cause of the high risk of premature death in these patients [4,5,6,7].…”

mentioning

confidence: 99%

Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain

et al. 2003

View full text Add to dashboard Cite

Aims/hypothesis. The aim of this study was to determine the incidence, prevalence and coronary heart disease risk in patients with known Type 2 (non-insulindependent) diabetes mellitus in a Basque Country sentinel practice network study. Methods. During the year 2000 we did a survey among sentinel practitioners who registered information about previously and newly diagnosed Type 2 diabetic patients older than 24 years of age. We studied 65,651 people attending a primary care service in the Basque Country Health Service-Osakidetza. We collected information about diabetic complications and cardiovascular risk factors and measured the coronary heart disease risk in these patients. Results. In the year 2000, the standardized cumulative incidence and prevalence of known Type 2 diabetes were 5.0 per 1000 (CI 95%: 4.9-5.1) and 4.6% (CI 95%: 4.5-4.7) respectively. Macroangiopathy was the most frequent complication both in the newly diagnosed (21.6%) and previously known Type 2 diabetic patients (33%). Total cholesterol ≥5.17 mmol/l and LDL cholesterol ≥2.58 mmol/l were found in 75% and 90% of newly diagnosed and 65% and 85% of previously diagnosed Type 2 diabetic patients respectively. Of the Type 2 diabetic patients 42% were obese and 80% had high blood pressure. More than 55% of the men compared with 44% of the women with Type 2 diabetes had high or very high risk of coronary heart disease (p<0.05). Conclusion/interpretation. We report new epidemiological data on known Type 2 diabetes in the Basque Country. These patients have a high frequency of cardiovascular risk factors causing a high coronary heart disease risk. [Diabetologia (2003) 46:899-909]

show abstract

Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population

Cited by 319 publications

References 0 publications

Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease

Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease

CKD and the Risk of Incident Cancer

Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain

Contact Info

Product

Resources

About